Whole‐exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations
The Journal of Dermatology · 2023-08 · 50 (8) · 1072-1075
DOI: 10.1111/1346-8138.16784 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 20.03.2023. Verfasst von Yoon-Seob Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Nevus, Skin Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: MD-Phd/Medical Scientist Training Program through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea, National Research Foundation of Korea, Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea.
Abstract (Originalsprache)
Nevus sebaceous (NS) is a congenital hamartoma associated with an increased risk of secondary neoplasms in approximately 10%–20% of patients. However, additional genomic alterations underlying tumorigenesis in NS lesions have not been clarified. We performed whole‐exome sequencing of archived tumor tissues ( n = 8; six basal cell carcinomas and two trichoepitheliomas) and matched germline tissues ( n = 7) with from seven patients with secondary tumors arising from NS. We also analyzed NS lesions without secondary tumors ( n = 8). Somatic mutations and copy number alterations (CNAs) were analyzed. We identified a median of 129 somatic mutations (corresponding to 2.6/Mb in target regions, range 26–336) for eight tumors, while a median of 118 somatic mutations (2.3/Mb, range 1–196) for eight NS lesions. Known RAS hotspot mutations were found in seven of the eight tumors (six for HRAS p.G13R and one for HRAS p.Q61R) and in six of the eight NS lesions (four for HRAS p.G13R, one for KRAS p.G12C, and one KRAS p.G12D). Except RAS mutations, several putative driver mutations were detected in tumors: TP53 p.F134L/p.R213*, MYCN p.P59L, OR2Z1 p.P167S, PTPN14 p.Q768*, and SMO p.W535L. As for CNAs, two tumors harbored copy‐loss in regions encompassing PTCH1 gene. However, eight NS lesions did not harbor both putative driver mutations and CNAs. In conclusion, our study revealed that secondary tumors arising from NS harbor known RAS hotspot mutations and additional genomic alterations, including putative driver mutations and PTCH1 copy‐loss. These results could help to define the high‐risk group for tumor development in patients with NS and provide evidence for prophylactic resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Precision Medicine Research Center/IRCGP, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Yoon-Seob Kim, Gyeong Sin Park, Yeun-Jun Chung, Ji Hyun Lee
Förderung
- MD-Phd/Medical Scientist Training Program through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea
- National Research Foundation of Korea
- Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea
- Korea Health Industry Development Institute
Zitieren
APA
Kim, Y. S., Park, G. S., Chung, Y. J., & Lee, J. H. (2023). Whole‐exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations. The Journal of Dermatology, 50(8), 1072-1075. https://doi.org/10.1111/1346-8138.16784
Vancouver
Kim YS, Park GS, Chung YJ, Lee JH. Whole‐exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations. The Journal of Dermatology. 2023;50(8):1072-1075. doi:10.1111/1346-8138.16784
BibTeX
@article{Kim2023,
author = {Kim, Yoon-Seob and Park, Gyeong Sin and Chung, Yeun-Jun and Lee, Ji Hyun},
title = {Whole‐exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations},
journal = {The Journal of Dermatology},
year = {2023},
volume = {50},
number = {8},
pages = {1072--1075},
doi = {10.1111/1346-8138.16784}
}
EUVIMED